The History and Current State of Antidepressant Clinical Trial Design
Alan J. Gelenberg(University of Arizona), J F Rosenbaum(Unknown), Helena C. Kraemer(Stanford University), Roger E. Meyer(Building Engineering and Science Talent), William Z. Potter(National Heart Lung and Blood Institute), Philip T. Ninan(Emory University), Madhukar H. Trivedi(Southwestern Medical Center), Maurizio Fava(Unknown), Michael E. Thase(Veterans Health Administration), Arif Khan(Nord University), Husseini K. Manji(National Institutes of Health), John Mann(Columbia University), Jean Endicott(Washington University in St. Louis), Frederick K. Goodwin(George Washington University), James H. Kocsis(Cornell University), Andrew C. Leon(Washington University in St. Louis), Richard C. Shelton(University of Maryland, College Park), Martin M. Katz(The University of Texas at San Antonio Health Science Center), Susan E. Bergeson(Digital Research Alliance of Canada)
Cited by 79
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
|Archives of General Psychiatry|2002|2.1k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder
|Archives of General Psychiatry|2003|1.2k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k